The herein reported nanomolar concentration of mTOR inhibitor everolimus in the combination with inhibitor of MAP kinase (AS-703026) or AKT kinase (MK-2206) pathway are sufficient to induce apoptosis, and reduce proliferation and invasiveness in melanoma cells. The gene discussed is MTOR; the disease is melanoma.